COVID-19 Expert Witnesses in Massachusetts

This highly qualified expert is board certified in pediatrics and pediatric infectious disease and has been practicing for 25+ years. He completed both his internship and residency trainings in pediatrics at North Shore University before concluding a fellowship program focusing on pediatric infectious disease at the same institution. He is a fellow at the American Academy of Pediatrics. He has published 21+ peer-reviewed journal articles and serves as a reviewer for 3 renowned pediatric journals. He lectures both nationally and internationally and has been listed as one of the "Best Doctors in America" for 12 consecutive years. He is currently an Associate Professor, Pediatrics, at a major New York Hospital and Pediatric Program Director and Vice Chairman for Education at a major children's hospital.

In the field of Epidemiology, this expert is exceptionally innovative and decorated for her contribution to cancer research. She began her career at SUNY Buffalo, graduating summa cum laude with a BS in Psychology. She continued on at SUNY to complete her Master and PhD in Epidemiology with her thesis and dissertation respectively focusing on gynecological cancer. She has maintained an unparalleled track-record of peer-reviewed publications, over 200 to date. She has coauthored four book chapters and has a vigorous research portfolio supported by millions of dollars in grant funding for cancer research. She is currently a Distinguished Professor, Professor of Tumor Immunology, professor in the department of Social and Preventive Medicine and Professor of Oncology at a national cancer research institute. She is currently the Chair for a committee in the Ovarian Cancer Association Consortium and a member of the Scientific Advisory Board for the Exposure and Human Health committee with the EPA.

This highly qualified expert has over 30 years of experience in Infectious Diseases. He earned his MD at Columbia University. He went on to complete an Internship and a Residency in Internal Medicine at Brookdale Hospital Medical Center. He then completed a Fellowship in Infectious Diseases at SUNY Health Sciences Center. He is Board Certified in Internal Medicine and Infectious Diseases. He is active in his community at a Fellow in several medical societies, including the Society for Healthcare Epidemiology of America, and a member of several medical associations such as the American Society for Microbiology. This expert has given over 300 lectures, authored over 100 publications, written 6 books, and written 10 book chapters on topics relating to his field. He has held the position of Chief of Infectious Diseases at Catholic Medical Center of Brooklyn & Queens and Saint Vincent Catholic Medical Centers, and has also served as the President and CEO of St. Joseph Hospital. He has also held positions as an Associate Professor of Medicine at Albert Einstein College of Medicine and SUNY Health Science Center at Stony Brook. Currently, he serves as the Chairman of the Department of Medicine and a Hospital Epidemiologist at a Major Hospital in New York, and a Clinical Professor of Medicine at a Medical School in New York.

This expert is Professor of Epidemiology in the School of Public Health at the one of the Top Universities in the US. He received his MD degree from UC San Diego and his PhD from the University of Chicago. After serving as a Postdoctoral Fellow in Epidemiology at the prestigious University of Washington Public Health School, he was an Associate Professor of Epidemiology and Biostatistics at the University of Toronto before moving to his current position more than two decades ago. His research interests are in the areas of cancer etiology and prevention, as well as in epidemiological analytic and field methods, and in evaluation of causation. His major research projects include studies of diverse risk and genetic factors for ovarian, pancreatic, lung, bladder, liver, endometrial, esophageal and stomach cancers, as well as studies related to the use of hormonal medications, analgesics, and other drugs. He is Associate Editor of a National Cancer Publication, Editor of an International Cancer Publication, and a Member of the Board of Editors for the American Journal of Epidemiology. This expert has reviewed a number of legal cases involving several major drugs and other agents and postmarketing adverse effects, and has experience in depositions.

This double board certified expert has been practicing for more than 30 years. Fellowship trained in Infectious Disease, she holds membership in the Infectious Disease Societies of New York and America and in the American Society of Microbiology. She has been published in professional journals such as "Journal of Clinical Microbiology" and "Infectious Disease Clinics of North America", and she has been honored in publications such as Top Internal Medicine and Infectious Disease Specialists and Leading Physicians of the World. Currently, this expert is a Clinical Assistant Professor at a major medical university as well as an Infectious Disease Specialist and the Executive Director of a private medical practice.

This double board certified expert has been practicing for over 20 years. He completed his Infectious Disease fellowship at Cornell University as well as a research fellowship at the Memorial Sloan-Kettering Cancer Center. Awarded the honor of Fellow of both the Infectious Diseases Society of America and the American College of Physicians, he holds membership in a multitude of other prestigious medical organizations and serves as a reviewer for over 40 medical journals. He is also extensively published with over 200 peer-reviewed journal articles, book chapters, and abstracts. Currently, this expert is an Associate Professor in the Department of Infectious Diseases at a major medical university, where he is also the Director of Transplant Infectious Diseases. His specific infectious disease experience includes tuberculosis, hepatitis, lyme disease, fungal infections, diseases of travel, infections in transplant recipients, bone and joint infections, and infections associated with targeted immunotherapy.